diabetic.
Conditions
Interventions
Intervention 1: Antibiotic treatment with 25% Pistacia atlantica cream. Intervention 2: Antibiotic treatment for diabetic ulcer with mupirocin cream.
Sponsors
Fasa University of Medical Sciences
Eligibility
Sex/Gender
All
Age
20 Years to 55 Years
Inclusion criteria
Inclusion criteria: Patients with diabetic foot ulcers aged between 20 and 55 years old (at most 2 weeks have passed since the onset of the ulcer) The patient's blood sugar should be under control, the blood sugar should be below 7.5 for three months Having diabetic foot ulcers without osteomyelitis (having various ulcers on the right or left foot with moderate inflammation that has not reached the stage of osteomyelitis) Not using corticosteroids and immunosuppressive drugs Wound with Wegener grade 2 Ulcers in the lower limbs Not having a history of allergy to medicinal plants Having no history of liver and heart disease, pregnancy and pregnancy, porphyria and lupus malignancy No history of surgery in the last 6 months Hemodynamically stable
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Wound size. Timepoint: the beginning of the study (before the start of the intervention); 3; 5; 9; 13; 17; 21; 25; 30 days after starting to use the cream. Method of measurement: ruler.;Infection. Timepoint: the beginning of the study (before the start of the intervention); 3; 5; 9; 13; 17; 21; 25; 30 days after starting to use the cream. Method of measurement: Clinical examination.;Type of secretions. Timepoint: the beginning of the study (before the start of the intervention); 3; 5; 9; 13; 17; 21; 25; 30 days after starting to use the cream. Method of measurement: Clinical examination.;The amount of secretions. Timepoint: the beginning of the study (before the start of the intervention); 3; 5; 9; 13; 17; 21; 25; 30 days after starting to use the cream. Method of measurement: Clinical examination.;Hospitalization day. Timepoint: the beginning of the study (before the start of the intervention); 3; 5; 9; 13; 17; 21; 25; 30 days after starting to use the cream. Method of measurement: Clinical examination.;Background disease. Timepoint: the beginning of the study (before the start of the intervention); 3; 5; 9; 13; 17; 21; 25; 30 days after starting to use the cream. Method of measurement: Clinical examination.;Redness of the wound. Timepoint: the beginning of the study (before the start of the intervention); 3; 5; 9; 13; 17; 21; 25; 30 days after starting to use the cream. Method of measurement: Clinical examination.;Edema. Timepoint: the beginning of the study (before the start of the intervention); 3; 5; 9; 13; 17; 21; 25; 30 days after starting to use the cream. Method of measurement: Clinical examination.;Bruising around the wound. Timepoint: the beginning of the study (before the start of the intervention); 3; 5; 9; 13; 17; 21; 25; 30 days after starting to use the cream. Method of measurement: Clinical examination.;Being warm around. Timepoint: the beginning of the study (before the start of the intervention); 3; 5; 9; 13; 17; 21; 25; 30 days after starting to | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSara Shafiee Bidshahi
Fasa University of Medical Sciences
Outcome results
None listed